IMMOBILISATION DEVICE
20210052344 ยท 2021-02-25
Inventors
Cpc classification
C08J2445/00
CHEMISTRY; METALLURGY
C08L65/00
CHEMISTRY; METALLURGY
B29L2031/753
PERFORMING OPERATIONS; TRANSPORTING
C08J2467/04
CHEMISTRY; METALLURGY
C08L67/04
CHEMISTRY; METALLURGY
C08L65/00
CHEMISTRY; METALLURGY
B29C51/002
PERFORMING OPERATIONS; TRANSPORTING
C08L67/04
CHEMISTRY; METALLURGY
B29K2096/00
PERFORMING OPERATIONS; TRANSPORTING
A61L31/14
HUMAN NECESSITIES
C08J2367/04
CHEMISTRY; METALLURGY
A61B90/18
HUMAN NECESSITIES
International classification
A61B90/18
HUMAN NECESSITIES
A61L31/14
HUMAN NECESSITIES
B29C51/00
PERFORMING OPERATIONS; TRANSPORTING
C08L67/04
CHEMISTRY; METALLURGY
Abstract
The present invention relates to a template for a positioning, fixation, mobilization or immobilization device, wherein the template comprises a sheet of a thermoplastic material, wherein the thermoplastic material comprises between 3.0 and 95.0 wt. % of a poly--caprolactone polymer, preferably a poly--caprolactone homopolymer, and at least 5.0 wt. % of at least one second polymer material with a melting temperature of between 40 and 85 C., wherein the at least one second polymer material is selected from the group of one or more of a polyalkenamer or a thermoplastic linear polyurethane which contains as a polyol a poly -caprolactone or a polyester polyol, wherein the poly--caprolactone polymer and the second thermoplastic material are cross-linked.
Claims
1. A template for a positioning, fixation, mobilization or immobilization device, wherein the template comprises a sheet of a thermoplastic material, wherein the thermoplastic material comprises between 3.0 and 95.0 wt. % of a poly--caprolactone polymer, preferably a poly--caprolactone homopolymer, and at least 5.0 wt. % of at least one second polymer material with a melting temperature of between 40 and 85 C., wherein the at least one second polymer material is selected from the group of one or more of a polyalkenamer or a thermoplastic linear polyurethane which contains as a polyol a poly -caprolactone or a polyester polyol, wherein the poly--caprolactone polymer and the second thermoplastic material are cross-linked.
2. A template according to claim 1, wherein the poly--caprolactone polymer is present in the thermoplastic material in a concentration of between 15.0 and 90.0 wt. %, preferably between 20.0 wt. % and 85.0 wt. %.
3. A template according to claim 1, wherein the thermoplastic polyurethane is present in the thermoplastic material in a concentration of between 5.0 and 97.0 wt. %, preferably between 10.0 and 85.0 wt. %, more preferably between 15.0 and 80.0 wt. %.
4. A template according to claim 1, wherein the thermoplastic polyalkenamer is present in the thermoplastic material in a concentration of 5 wt. % up to 20.0 wt. %, preferably of 7.5 wt. % up to 15.0 wt. %.
5. A template according to claim 1, wherein the poly--caprolactone has a number average molecular weight Mn of at least 10.000 g/mole, more preferably at least 20.000 g/mole, most preferably at least 40.000 g/mole, in particular at least 50.000 g/mole.
6. A template according to claim 1, wherein the poly--caprolactone has a number average molecular weight Mn of maximum 100.000 g/mole, preferably maximum 90.000 g/mole.
7. A template according to claim 1, wherein the poly--caprolactone has a melting temperature of between 40 and 70 C., preferably between 50 and 70 C., more preferably between 55 and 65 C.
8. A template according to claim 1, wherein the poly--caprolactone contains between 35 and 70 wt. % of crystalline poly--caprolactone with respect to the weight of the poly--caprolactone, preferably between 40.0 and 65.0 wt. %, more preferably between 55 and 60 wt. %.
9. A template according to claim 1, wherein the poly--caprolactone units of the thermoplastic linear polyurethane have a number average molecular weight Mn of at least 1000 g/mole, preferably at least 2000 g/mole, more preferably at least 2500 g/mole, most preferably at least 5000 g/mole, and maximum 10000 g/mole, preferably maximum 5000 g/mole, more preferably maximum 2500 g/mole.
10. A template according to claim 1, wherein the poly--caprolactone based polyurethane has a melting temperature of between 40 and 70 C., preferably between 50 and 70 C.
11. A template according to claim 1, wherein the thermoplastic material has a molding time of between 1 and 15 minutes, preferably between 1 and 10 minutes, after having been heated to the melting temperature.
12. A template according to claim 1, wherein the polyalkenamer is a polyoctenomer, having a melting temperature ranging between 5 and 80 C., preferably between 20 C. and 70 C., more preferably between 30 C. and 65 C., most preferably between 50 C. and 60 C.
13. A method for producing a template according to claim 1, wherein a thermoplastic material comprising between 3.0 and 95.0 wt. % of a poly--caprolactone polymer is blended with at least 5.0 wt. % of at least one second thermoplastic material with a melting temperature of between 40 and 85 C., wherein the at least one second polymer material is selected from the group of one or more of a polyalkenamer or a thermoplastic linear polyurethane which contains as a polyol a poly -caprolactone or a polyester polyol, and with 0.2-10.0 wt. % of a cross-linking initiator based on the weight of the thermoplastic material, formed into a sheet and subjected to cross-linking to at least partially cross-link the thermoplastic material.
14. A method according to claim 13, wherein the template is perforated in advance of being subjected to cross-linking.
15. A method according to claim 13, wherein cross-linking involves a first step of partial cross-linking of the thermoplastic material after it has been shaped into a sheet, and a second step of further cross-linking before the sheet of thermoplastic material is shaped into an immobilization device.
16. A method for shaping a template according to claim 1, to a part of a body of a living subject that needs to be positioned, mobilised or immobilised, wherein a thermoplastic material according to any one of claims 1-12 is heated to a temperature of between 40 and 85 C., preferably between 50 and 75 C., more preferably between 60 and 75 C., positioned on the body part, shaped to conform to the contours of the body part and left to cool.
17. Use of a sheet of thermoplastic material for the production of a template according to claim 1, wherein the thermoplastic material comprises between 3.0 and 95.0 wt. % of a poly--caprolactone polymer, preferably a poly--caprolactone homopolymer, and at least 5.0 wt. % of at least one second polymer material with a melting temperature of between 40 and 85 C., wherein the second polymer material is selected from the group of one or more of a polyalkenamer or a thermoplastic linear polyurethane which contains as a polyol a poly -caprolactone or a polyester polyol, wherein the poly--caprolactone and the at least one second thermoplastic material are cross-linked.
18. A sheet of thermoplastic material as part of a template according to claim 1, wherein the thermoplastic material comprises between 3.0 and 95.0 wt. % of a poly--caprolactone polymer, preferably a poly--caprolactone homopolymer, and at least 5.0 wt. % of at least one second polymer material with a melting temperature of between 40 and 85 C., wherein the second polymer material is selected from the group of one or more of a polyalkenamer or a thermoplastic linear polyurethane which contains as a polyol a poly -caprolactone or a polyester polyol, wherein the poly--caprolactone and the second thermoplastic material are cross-linked.
19. An immobilisation device comprising a template according to of claim 1 molded into a shape that permits immobilization of a desired body part.
20. A method for producing an immobilisation device, wherein a template according to claim 1 is heated to a temperature between 40 and 85 C., preferably between 40 and 70 C., more preferably between 50 and 70 C., most preferably between 55 and 65 C., positioned on the body part that needs to be positioned, mobilised or immobilised, shaped to conform to the contours of the body part and left to cool.
21. An immobilisation device comprising a sheet according to claim 18 molded into a shape that permits immobilization of a desired body part.
Description
EXAMPLE 1 AND 2
[0071] Two blends were prepared of [0072] poly--caprolactone (PCL) with a number averaged molecular weight Mn of about 50000 and a melting range of between 58 and 60 C., [0073] and a polyoctenamer (POM) with a trans-double bond content of nearly 80%, a molecular weight of 90000, a melting point of 54 C.,
in the amounts indicated in the table 1 below.
The blend further contained 1.0 wt. % of triallyl isocyanurate as a cross-linking initiator. The triallyl isocyanurate was incorporated into the PCL and its amount is included in the amount of PCL in table 1.
[0074] The blend was mixed in a twin screw extruder at 130 C., cooled and formed into granules. An amount of granules was heated to a temperature of 130 C. and press molded into a thermoplastic sheet with a thickness of 2.0 mm and a size of 250250 mm, using an hydraulic press of Agila model PE30.
[0075] The thermoplastic sheet was subjected to cross-linking by subjecting it to irradiation doses of 5 KGy. The properties of the cross-linked sheet are summarized in Table 1 below.
TABLE-US-00001 TABLE 1 3-Point- Time of isometric crystallisation Bending Max. Flexural PCL POM Crystallistion 50% Full contraction Modulus Ex. wt. %* wt. % onset* crystallisation* crystallisation** load (N) (MPa) 1 95 5 2 m 15 s 5 m 10 s 19 m 46.9 491 2 85 15 2 m 30 s 5 m 45 s 21 m 42.18 444 *the poly--caprolactone contained 1.5 wt. % of the usual additives **in minutes (m) and seconds (s)
[0076] The memory, measured after reheating of samples which had been subjected to stretching, with a degree of stretching of 70% at 65 C., was almost 100% for each of the samples. This means that the samples which had been subjected to 70% stretching at 65 C., followed by cooling to room temperature in the stretched condition while being fixed to a support member, and which were thereafter reheated to 65 C., returned to their initial shape upon coolingalso when not fixed to a support member.
[0077] From table 1 it can be concluded that by incorporation of the polyoctenamer into the thermoplastic poly -caprolactone, the period of time which elapsed before crystallization started and that the time available up to full crystallization of the material, could be increased. As a result, more time remains available for the moulding of a sheet of thermoplastic material according to the invention, onto a body part to be immobilized, into a desired shape.
[0078] As can be understood from table 1, with an increasing degree of substitution of poly--caprolactone, the material of the thermoplastic sheet was sensed by the test persons as softer to the skin.
EXAMPLE 3-4 AND COMPARATIVE EXAMPLE A
[0079] A blend was prepared of varying amounts of [0080] poly--caprolactone (PCL) with a number averaged molecular weight Mn of about 50000 and a melting range of between 58 and 60 C., and [0081] a linear thermoplastic polyurethane (PU), which contained poly--caprolactone units as a polyol with a melting range of 65-71 C.,
in the amounts indicated in the table 2 below. The blend further contained about 1 wt. % of triallyl isocyanurate as a cross-linking agent. The triallyl isocyanurate was incorporated into the PCL and its amount is included in the amount of PCL in table 1.
[0082] The blend was subjected to melt mixing with a twin screw extruder at 130 C., thereafter cooled and granulated. The thus obtained granules were heated to a temperature of 130 C., and press molded into a sheet with a thickness of 2.0 mm and a size 250250 mm using an hydraulic press of Agila model PE30. The thermoplastic sheet was subjected to cross-linking by subjecting it to -irradiation. of 5 KGy.
[0083] The properties of the cross-linked sheet are summarized in table 2 below.
[0084] From table 2 it can be concluded that by incorporation of polyurethane into the poly--caprolactone, the time available up to the start of the crystallization, as well as the time available up to full crystallization of the material increased. As a result, more time remains available for the moulding of a sheet onto the body part to be immobilized, into a desired shape.
[0085] With an increasing degree of substitution of PCL, the material of the thermoplastic sheet was sensed by the test persons as softer to the skin.
TABLE-US-00002 TABLE 2 Time of isometric crystallisation Crystallisation Maximum contraction Ex. PCL wt. % PU wt. % onset (min s) load (N) A 100 0 1 m 30 s 50 3 90 10 2 m 00 s 47 4 3 97 3 m 30 s 22 * the poly--caprolactone contained 1.5 wt. % of the usual additives ** in minutes (m) and seconds (s)
EXAMPLE 5-6
[0086] A 3 points fixation mask was cut from a perforated sheet that had been produced from the mixtures of polyoctenamer and poly--caprolactone of example 1 and 2. The mask was heated to a temperature of 65 C. and molded on a dummy head. The fixation/shrinkage force Fv was measured during cooling of the mask after 30 min and 24 h by using the method described in a patent application BE 1015081. The results are presented in Table 3.
[0087] From Table 3 it can be concluded that by incorporation of the polyoctenamer the shrinkage force of immobilization mask decreased which will increases the comfort of the patient.
TABLE-US-00003 TABLE 3 Mask - Shrinkage Force (Fv) Fv (30 min) Fv (24 hours) Ex. PCL wt. % POM wt. % (N) (N) 5 95 5 123 190 6 85 15 110 163 * the poly--caprolactone contained 1.5 wt. % of the usual additives
EXAMPLE 7-8 AND COMPARATIVE EXAMPLE B
[0088] A 3 points fixation masks was cut from a maximally perforated sheet produced from a thermoplastic material that contained both poly--caprolactone and a linear polyurethane with poly--caprolactone diol. The mask was heated or activated at 65 C. and molded on a dummy head. The fixation/shrinkage force Fv was measured during cooling of the mask after 30 min and 48 hours. The measured test results are presented in Table 4.
TABLE-US-00004 TABLE 4 Properties of 3 points fixation masks based on composition of PCL and PU. Shrink and Stability Fv (30 min) Fv (48 hours) Ex. PCL wt % PU wt. % (N) (N) B 100 0 75 170 7 85 15 60 150 8 70 30 50 120 * the poly--caprolactone contained 1.5 wt. % of the usual additives
From Table 4 it can be concluded that by incorporation of the linear PU containing poly--caprolactone diol, the shrinkage force Fv of the immobilization mask could be reduced, which will increases the comfort of the patient.